Caner Saygin to Leukemia, Myelomonocytic, Chronic
This is a "connection" page, showing publications Caner Saygin has written about Leukemia, Myelomonocytic, Chronic.
Connection Strength
0.334
-
Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies. Blood Adv. 2021 04 27; 5(8):2264-2271.
Score: 0.190
-
Genomic determinants of chronic myelomonocytic leukemia. Leukemia. 2017 12; 31(12):2815-2823.
Score: 0.145